← All companies

NTLA

Intellia Therapeutics, Inc.

NTLA Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗

$10.77

-0.32 -2.89%

Key statistics

from XBRL data in SEC filings

Market cap

$1.50B

Revenue (TTM)

$66.1M

Net income (TTM)

-$395M

EPS (TTM)

$-3.52

P/E ratio

—

Dividend yield

—

Free cash flow

-$396M

Cash

$135M

Total assets

$759M

Gross margin

—

52-week range

$7.95 – $28.25

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jun 15, 2026 8-K Shareholder vote results Jun 10, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 8-K Entered a material agreement; Results of operations (earnings release) Apr 30, 2026 8-K Regulation FD disclosure; Other events Apr 27, 2026 8-K Amended charter or bylaws Apr 10, 2026 8-K Entered a material agreement; Regulation FD disclosure; Other events Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure; Other events Jan 27, 2026 8-K Regulation FD disclosure; Other events Jan 9, 2026 8-K Regulation FD disclosure; Other events Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Oct 29, 2025 8-K Regulation FD disclosure; Other events Oct 27, 2025 8-K Regulation FD disclosure; Other events Sep 25, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Director or officer change Aug 7, 2025 8-K Regulation FD disclosure; Other events Jun 16, 2025 8-K Director or officer change; Shareholder vote results Jun 12, 2025 8-K Regulation FD disclosure; Other events May 28, 2025 8-K Regulation FD disclosure; Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Amended charter or bylaws Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation Feb 21, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change; Regulation FD disclosure; Other events Jan 10, 2025 8-K Regulation FD disclosure; Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Regulation FD disclosure; Other events Oct 25, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change; Regulation FD disclosure Jun 26, 2024 8-K Director or officer change; Regulation FD disclosure Jun 14, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 13, 2024